Skip to main navigation Skip to search Skip to main content

Fibroblast Activation Protein–Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

  • Lukas Kessler
  • , Felix Schwaning
  • , Martin Metzenmacher
  • , Kim Pabst
  • , Jens Siveke
  • , Marija Trajkovic-Arsic
  • , Benedikt Schaarschmidt
  • , Marcel Wiesweg
  • , Clemens Aigner
  • , Till Plones
  • , Kaid Darwiche
  • , Servet Bolukbas
  • , Martin Stuschke
  • , Lale Umutlu
  • , Michael Nader
  • , Dirk Theegarten
  • , Rainer Hamacher
  • , Wilfried E.E. Eberhardt
  • , Martin Schuler
  • , Ken Herrmann
    • Wolfgang P. Fendler, Hubertus Hautzel
  • University Hospital of Essen
  • German Cancer Research Center
  • Medical University of Vienna
  • Universitätsklinikum Carl Gustav Carus Dresden
  • National Center for Tumor Diseases (NCT/UCC) Dresden
  • HelmholtzZentrum Dresden-Rossendorf

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Fibroblast Activation Protein–Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science